SGHuang Jing Han, a 41-year-old woman from Singapore, was diagnosed with ALS (amyotrophic lateral sclerosis) in 2017 after experiencing symptoms such as speech slurring and difficulty walking. ALS is a progressive, fatal neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. In Singapore, between 250 and 400 people live with ALS, with 30 to 50 new cases diagnosed annually. Dr. Crystal Yeo, a neurologist at the National Neuroscience Institute, is using artificial intelligence to analyze patient data and better predict how ALS progresses in individuals. This approach aims to provide personalized care tailored to each patient's needs. Research suggests that ALS onset occurs earlier in Asian populations compared to Caucasians, and patients in Asia tend to live longer with the disease. Yeo noted that ALS is not a single disease but a group of related conditions with varying biological underpinnings.
Bias read (Center): The article discusses medical research and health-related advancements in predicting the progression of ALS using AI. It does not present any political opinions, biases, or controversial viewpoints. The content focuses on scientific developments and patient experiences without leaning toward any ide
